Concerning endothelial dysfunction, it has been reported that the silencing of Prx2 in human aortic endothelial cells caused the inactivation of VEGF receptor 2 (VEGFR2) by oxidation, reducing chemotactic mobility and proliferation in response to VEGF [80]. The gene discussed is KDR; the disease is endothelial dysfunction.